Last reviewed · How we verify
NCT04454554: PEDIS
Prevalence of Pulmonary Embolism in Patients With Dyspnea on Exertion (PEDIS)
trial in Pulmonary Embolism in 400 participants. Completed in 30 January 2021.
24 December 2020
Quick facts
| Lead sponsor | Arianna Anticoagulazione Foundation |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 400 |
| Start date | 24 September 2018 |
| Primary completion | 24 December 2020 |
| Estimated completion | 30 January 2021 |
| Sites | 1 location across Italy |
Conditions studied
- Pulmonary Embolism — all drugs for Pulmonary Embolism →
Sponsor
Arianna Anticoagulazione Foundation
Who can join
Adults 18 to 75, any sex, with Pulmonary Embolism. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
PEDIS Study is an observational, cross-sectional, multicenter Italian study conducted in a consecutive series of patients who refer to the Emergency Departments (either spontaneously or sent by their attending physicians) for the recent (less than one months) development of exertional dyspnea. The general aim of the study is to assess the prevalence of PE in the overall population referring to the Emergency Departments without potential explanations for dyspnea
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04454554
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pulmonary Embolism
Currently open trials in the same condition.
- NCT07381712 — High-Flow Nasal Cannula Versus Non-Invasive Ventilation for Acute Respiratory Failure in Pulmonary Embolism. · NA · active not recruiting
- NCT04211181 — CHIPs-VTE Study in Hospitalized Patients to Prevent Hospital-Acquired Venous Thromboembolism · NA · recruiting
- NCT07003646 — Reperfusion Treatment in Acute Pulmonary Embolism · recruiting
- NCT06600542 — Inari VISION Registry · recruiting
- NCT06622876 — Incidental Discovery of Pulmonary Emboli Via CT Scan: Impact of Detections on Patient Care and Resulting Complications · recruiting
Other Arianna Anticoagulazione Foundation trials
Trials by the same sponsor.
- NCT04257487 — Sulodexide, VESSEL®, for the Prevention of Recurrent Venous Thromboembolism (The Jason Study) · Phase 3 · recruiting
- NCT03678506 — Apixaban for Extended Anticoagulation (APIDULCIS) · Phase 4 · terminated
- NCT03803579 — Baseline Concentration of Direct Oral Anticoagulant and Incidence of Adverse Event Measure And See (MAS) · completed
- NCT04646993 — WHITE Study: WHIch Decision After a First Venous ThromboEmbolism? · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04454554 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Arianna Anticoagulazione Foundation
- Last refreshed: 19 March 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04454554.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing